ActiGraph Establishes New Scientific Advisory Board
ActiGraph has formally established an advisory board of leading digital and clinical research experts to guide its scientific strategy.
The members of this new Scientific Advisory Board were selected for their experience in using digital health technologies across a wide spectrum of therapeutic areas. These perspectives will provide ActiGraph with guidance to ensure the company’s platform and solutions are optimized and fit-for-purpose for clinical research and care.
The first five members are: Rohit Aggarwal, MD, Tina Duong, MPT, PhD, Richard Keefe, PhD, Emmanuel Mignot, MD, PhD, and Eric Perakslis, PhD.
Read more about the advisory board and its first members here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer
June 10th 2025In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.
